BIGAN is a personal AI companion that provides reference frameworks and informational guidance for pharmaceutical and biotech professionals. BIGAN is offered as a personal subscription service by ahme, Inc.
Content produced by BIGAN — including documents, frameworks, analyses, and conversational responses — is provided as informational reference material. Any output intended for use in regulated activities must be reviewed, modified, and approved through your organization's quality system before use. You are responsible for ensuring all outputs meet your organization's requirements.
BIGAN subscriptions are personal and individual. You agree to maintain accurate account information, keep your credentials secure, and use BIGAN only for lawful professional purposes. Sharing accounts is not permitted.
BIGAN is offered as a paid subscription. Subscription terms, billing cycles, and cancellation policies will be detailed in the final Terms of Service. Preview cohort participants will receive specific terms regarding their preview period and any subsequent transition to a paid plan.
You agree not to use BIGAN to:
BIGAN's software, design, content frameworks, and underlying knowledge architecture are owned by ahme, Inc. Content you create using BIGAN — your conversations, generated documents — is yours, subject to the use restrictions described above.
BIGAN is provided "as is" without warranty. ahme is not liable for any decisions, regulatory outcomes, or business consequences resulting from BIGAN's outputs. The full Terms will detail these limitations under applicable law.
Contact us at info@ahme.ai with any questions while the full Terms of Service are being finalized.